Related Experiment Video
Updated: Mar 22, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Allen Cognitive Level Screen for the classification of subjects treated for addiction
Gloria Rojo-Mota1,2, Eduardo J Pedrero-Pérez1, Elisabet Huertas-Hoyas2
1a Institute of Addictions. Madrid Salud , Madrid , Spain.
Abstract:
Introduction The Cognitive Disabilities Model (CDM) is an occupational approach that can allow the classification of the functional-cognitive abilities of persons with addictions. The objective of the study was to explore the applicability of the ACLS-5 to assess a sample of persons undergoing addiction-rehabilitation treatment. Methods A sample of 232 participants was recruited from an outpatient treatment centre in Madrid (Spain). The ACLS-5, the Montreal Cognitive Assessment (MoCA), and the Prefrontal Symptom Inventory (PSI) were administered. Sociodemographic and addiction-related data were also obtained. Results Half of the sample showed serious deficits in functional cognition, which ultimately could be related to problems in their daily performance. Scores of ACLS-5 showed significant correlations with the severity of addiction, with those obtained with the MoCA, and with attentional symptoms on the PSI scale. Conclusions The data suggest the applicability of the ACLS-5 in assessing the degree of functional cognition in subjects treated for addiction, providing evidence to support ecological validity and facilitating the development of well-targeted cognitive rehabilitation programmes from an occupational perspective. The use of occupational-based instruments to assess the functioning of those with addictions is a requirement of occupational therapy professionals working in this general area.
More Related Videos
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Drug Dependence
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
CNS Depressants: Alcohol and Nicotine

